REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA

Clinical trials for REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

Double attack on tough blood cancer: pill plus supercharged immune cells

Disease control Not yet recruiting

This study is testing if adding a daily pill called nemtabrutinib makes a personalized cell therapy more effective for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has returned or stopped responding to other treatments. The cell therapy,…

Matched conditions: REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA

Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA

Get alerted when new REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA trials appear

Double attack on tough blood cancer: pill plus supercharged immune cells